ResMed logo-fullcolor.jpg
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
08 juin 2023 09h00 HE | ResMed Inc.
The studies also showed 18-40% lower costs incurred from ER visits and hospitalizations after 1 year for PAP-adherent OSA patients with diastolic and systolic heart failure, respectivelyA third study...
new_logo.png
Cardiac Marker Testing Market to exceed USD 18.4 billion by 2032, Says Graphical Research Powered by GMI
30 mai 2023 17h00 HE | Graphical Research
Selbyville, Delaware, May 30, 2023 (GLOBE NEWSWIRE) -- Cardiac Marker Testing Market size will surpass USD 18.4 billion by 2032. The rising prevalence of cardiovascular diseases will boost the...
Daxor logo thumbnail.png
Daxor Corporation Announces Closing of $4.0 Million Underwritten Public Offering
25 mai 2023 15h37 HE | Daxor Corporation
Oak Ridge, TN, May 25, 2023 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the closing of...
Daxor logo thumbnail.png
New Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in Heart Failure Outcomes
18 mai 2023 08h00 HE | Daxor Corporation
Daxor’s BVA Technology Shown to Provide Unique and Individualized Data for Patient Management Oak Ridge, TN, May 18, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader...
Imbria_Logo_Colour.png
Imbria Pharmaceuticals to Participate in SVB Securities Biopharma Private Company Connect
17 mai 2023 08h00 HE | Imbria Pharmaceuticals Inc.
BOSTON, May 17, 2023 (GLOBE NEWSWIRE) -- Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies designed to enhance cellular energetics, today announced...
MicrosoftTeams-image (5).png
Defibrillator Market to Reach New Heights, Predicted to Surpass USD 16.3 Bn by 2031 Due to Rising Incidence of Cardiac Disease – Global Analysis by Transparency Market Research
12 mai 2023 06h30 HE | Transparency Market Research
Wilmington, Delaware, United States, May 12, 2023 (GLOBE NEWSWIRE) -- The global defibrillators market was valued at USD 7.2 Bn in 2021 and is projected to reach USD 16.3 Bn by 2031 growing at a...
NOVARTIS logo.jpg
Novartis Entresto receives positive CHMP opinion for pediatric heart failure
31 mars 2023 07h53 HE | Novartis Pharma AG
If subsequently approved, Entresto will be the first and only approved therapy for the treatment of symptomatic chronic heart failure patients aged 1 to <18 years in the European Union Pediatric...
MicrosoftTeams-image (5).png
Cardiology Stem Cells Market Revenue to Hit USD 5.1 Bn by 2031 | Transparency Market Research
16 mars 2023 09h00 HE | Transparency Market Research
Wilmington, Delaware, United States, March 16, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research study, the global cardiology stem cells market stood at US$ 2.6 Bn in 2022, and it...
MicrosoftTeams-image (5).png
Inotropic Agents Market Value to Surpass US$ 5.1 Bn by 2031: TMR Study
07 mars 2023 14h30 HE | Transparency Market Research
Wilmington, Delaware, United States, March 08, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – As per a TMR study, the Inotropic Agents Market was valued at US$ 1.9 Bn in 2022 and is...
logo 600X600.png
Global Tonometry Device Market to Surpass US$ 176.02 Million by 2030, Says Coherent Market Insights (CMI)
13 févr. 2023 09h15 HE | CMI
Burlingame, Feb. 13, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global tonometry device market is estimated to be valued at US$ 109.68 million in 2022 and is expected to...